Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06575322
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-23
Brief Title:
Effects of Neoadjuvant Therapy With Carboplatin Paclitaxel Combined With Anti-PD-1 Drugs on Pain Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Neoadjuvant Therapy With Carboplatin Paclitaxel Combined With Anti-PD-1 Drugs on Pain Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to learn about the Effects of neoadjuvant therapy with carboplatin paclitaxel combined with anti-PD-1 drugs on pain anxiety and depression in patients with operable head and neck squamous cell carcinoma a prospective cohort study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None